Quality of life ratings in dementia care – a cross-sectional study to identify factors associated with proxy-ratings

por Gräske, Johannes, Meyer, Saskia, Wolf-Ostermann, Karin
Publicado 2014

Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer

por Meyer, Saskia, Leusen, Jeanette HW, Boross, Peter
Publicado 2014

Family visits in shared-housing arrangements for residents with dementia – a cross-sectional study on the impact on residents’ quality of life

por Gräske, Johannes, Meyer, Saskia, Worch, Andreas, Wolf-Ostermann, Karin
Publicado 2015

Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo

por Mester, Simone, Evers, Mitchell, Meyer, Saskia, Nilsen, Jeannette, Greiff, Victor, Sandlie, Inger, Leusen, Jeanette, Andersen, Jan Terje
Publicado 2021

Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use

por Wübbeler, Markus, Wucherer, Diana, Hertel, Johannes, Michalowsky, Bernhard, Heinrich, Steffen, Meyer, Saskia, Schaefer-Walkmann, Susanne, Hoffmann, Wolfgang, Thyrian, Jochen René
Publicado 2015

PB2501: INSIGHT-1: A PHASE I FIRST-IN-HUMAN TCR TRIAL OF GENETICALLY MODIFIED T-CELLS TARGETING TDT IN CHILDREN AND ADULTS WITH T- AND B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA...

por Buechner, Jochen, Holth Rustad, Even, Meyer, Saskia, Gjerdingen, Thea, Giannakopoulou, Eirini, Ali, Muhammad, Weum Abrahamsen, Ingerid, Pasetto, Anna, Yuan, Ying, Olweus, Johanna
Publicado 2023

Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting

por Meyer, Saskia, Nederend, Maaike, Jansen, J.H. Marco, Reiding, Karli R., Jacobino, Shamir R., Meeldijk, Jan, Bovenschen, Niels, Wuhrer, Manfred, Valerius, Thomas, Ubink, Ruud, Boross, Peter, Rouwendal, Gerard, Leusen, Jeanette H.W.
Publicado 2015

Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies

por Evers, Mitchell, Ten Broeke, Toine, Jansen, J.H. Marco, Nederend, Maaike, Hamdan, Firas, Reiding, Karli R., Meyer, Saskia, Moerer, Petra, Brinkman, Iris, Rösner, Thies, Lebbink, Robert Jan, Valerius, Thomas, Leusen, Jeanette H.W.
Publicado 2020

Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants

por Meyer, Saskia, Blaas, Isaac, Bollineni, Ravi Chand, Delic-Sarac, Marina, Tran, Trung T., Knetter, Cathrine, Dai, Ke-Zheng, Madssen, Torfinn Støve, Vaage, John T., Gustavsen, Alice, Yang, Weiwen, Nissen-Meyer, Lise Sofie Haug, Douvlataniotis, Karolos, Laos, Maarja, Nielsen, Morten Milek, Thiede, Bernd, Søraas, Arne, Lund-Johansen, Fridtjof, Rustad, Even H., Olweus, Johanna
Publicado 2023

Rituximab‐treated patients with lymphoma develop strong CD8 T‐cell responses following COVID‐19 vaccination

por Riise, Jon, Meyer, Saskia, Blaas, Isaac, Chopra, Adity, Tran, Trung T., Delic‐Sarac, Marina, Hestdalen, Malu Lian, Brodin, Ellen, Rustad, Even Holth, Dai, Ke‐Zheng, Vaage, John Torgils, Nissen‐Meyer, Lise Sofie Haug, Sund, Fredrik, Wader, Karin F., Bjornevik, Anne T., Meyer, Peter A., Nygaard, Gro O., König, Marton, Smeland, Sigbjørn, Lund‐Johansen, Fridtjof, Olweus, Johanna, Kolstad, Arne
Publicado 2022